CurveBeam AI Limited (ASX:CVB)
Australia · Delayed Price · Currency is AUD 0.0190
0.00 (0.00%)
Oct 28, 2026, 10:22 AM AEDT
CurveBeam AI Market Cap
CurveBeam AI has a market cap or net worth of 14.59 million as of October 27, 2026. It is the 41,313th most valuable company in the world and the 1,186th biggest in Australia. Its market cap has decreased by 64.56% in one year.
Market Cap
14.59M
Enterprise Value
30.60M
Revenue
8.67M
Global Rank
Country Rank
#1,186 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 23, 2023, CurveBeam AI's market cap has decreased from 108.85M to 14.59M, a decrease of -86.59%. That is a compound annual growth rate of -46.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 14.59M | -57.85% |
| Dec 31, 2025 | 34.62M | -34.20% |
| Dec 31, 2024 | 52.62M | -60.39% |
| Dec 29, 2023 | 132.86M | 22.06% |
| Aug 23, 2023 | 108.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nova Eye Medical | 45.59M |
| HeraMED | 42.87M |
| Cleo Diagnostics | 40.45M |
| CleanSpace Holdings | 38.10M |
| Micro-X | 34.61M |
| Control Bionics | 28.78M |
| OncoSil Medical | 26.61M |
| ImpediMed | 14.65M |